University Medical Center Groningen
Groningen, Provincie Groningen, 9700 RB, Netherlands
NCT Number: NCT01549483
The purpose of this study is to study differences in small airways (<2mm) parameters in asthma patients, subjects with asymptomatic airway hyperresponsiveness and healthy controls.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Groningen, Provincie Groningen, 9700 RB, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for asymptomatic subjects with airway hyperresponsiveness (AHR) :
Inclusion criteria
for asymptomatic subjects without AHR :
Inclusion criteria
for patients with asthma:
Exclusion criteria
Time frame: visit 1
Difference between resistance at 5 Hz (R5) and resistance at 20 Hz (R20) (R5-20).
Time frame: visit 1
Forced expiratory flow between 25 and 75% of forced vital capacity (FEF25-75), alveolar nitric oxide (NO), residual volume (RV), RV/total lung capacity (TLC)
Time frame: visit 2
Time frame: visit 2
Resistance at 5 Hz (R5) during a bronchial provocation test with methacholine
University Medical Center Groningen
Other
Differences in Small Airways Disease Between Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness
Acronym: ABHR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00666510
Airway Hyperresponsiveness, Asthma
São Paulo, Brazil
View Trial DetailsNCT06644924
Asthma, Bronchial Diseases
Encinitas, California, United States
View Trial DetailsNCT06272370
Asthma, Bronchial Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05685381
Asthma, Bronchial Diseases
Beacon, New York, United States
View Trial Details